Company Greenrise Global Brands Inc.

XCX

CA39540L1085

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Alternative Medicine

Market Closed - Canadian Securities Exchange Other stock markets 10:35:35 2024-04-15 am EDT			5-day change	1st Jan Change
0.005 ^CAD	-66.67%		0.00%	-50.00%

2023	Greenrise Global Brands Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Greenrise Global Brands Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Greenrise Global Brands Inc. is a Canada-based investment holding company with investments in the cannabis industry in Germany. The Company, through CannaCare Health GmbH (CannaCare), offers a range of approximately 20 cannabidiol (CBD) products consisting of tinctures, sprays and oils and skincare products made from natural raw materials manufactured in Europe and Germany and distributed through traditional sales channels, such as www.cannacare-health.com and www.canobo.de. CannaCare is a producer and supplier of CBD wellness products and wholly owns AMP Alternative Medical Products GmbH (AMP), an importer and distributor of European Union-Good Manufacturing Practice (EU-GMP) medical cannabis to pharmacies.

Managers	Title	Age	Since
Tom Kusumoto CEO	Chief Executive Officer	54	12-12-13
Stefan Feuerstein BRD	Director/Board Member	72	18-12-04
Valeria Bravo Burgos IRC	Investor Relations Contact	-	18-12-31
Franziska Maisch SAM	Sales & Marketing	-	-
Stefan Blodgett PRN	Corporate Officer/Principal	-	-
Alexander Werner Hintz PRN	Corporate Officer/Principal	43	21-11-02
Robert Schenk SAM	Sales & Marketing	-	21-04-06
Marc Wälken SAM	Sales & Marketing	-	20-09-14

Members of the board	Title	Age	Since
Tom Kusumoto CEO	Chief Executive Officer	54	12-12-13
Stefan Feuerstein BRD	Director/Board Member	72	18-12-04
Frank Otto BRD	Director/Board Member	-	22-05-10
Oliver Schindler BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	47,236,039	35,004,904 ( 74.11 %)	0	74.11 %

Name	Equities	%	Valuation
Frank Otto 5.293 %	2,500,000	5.293 %	12 500 $
Oliver Schindler 4.350 %	2,055,000	4.350 %	10 275 $
Mercury Partners & Co. Plc 3.591 %	1,696,285	3.591 %	8 481 $
Tom Kusumoto 2.858 %	1,349,950	2.858 %	6 750 $
SEAMARK Asset Management Ltd. (New) 0.5838 %	275,775	0.5838 %	1 379 $
Stefan Feuerstein 0.4234 %	200,000	0.4234 %	1 000 $
Deans Knight Capital Management Ltd. 0.0910 %	42,975	0.0910 %	215 $
Blair Franklin Management, Inc. 0.0619 %	29,250	0.0619 %	146 $
NCM Asset Management Ltd. 0.0556 %	26,250	0.0556 %	131 $

Greenrise Global Brands, Inc.

224 West 5th Avenue

V5Y 1J4, Vancouver

http://www.greenriseglobal.com

address Greenrise Global Brands Inc.(XCX)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Alternative Medicine

	1st Jan change	Capi.
GREENRISE GLOBAL BRANDS INC.	-50.00%	173K
DONG-E-E-JIAO CO.,LTD.	+35.04%	5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B